[Federal Register Volume 86, Number 17 (Thursday, January 28, 2021)]
[Notices]
[Pages 7380-7382]
[FR Doc No: 2021-01875]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP21-26-000]

Transcontinental Gas Pipe Line Company, LLC; Notice of Request
Under Blanket Authorization and Establishing Intervention and Protest
Deadline

    Take notice that on January 12, 2021, Transcontinental Gas Pipe
Line Company, LLC (Transco), P.O. Box 1396, Houston, TX 77251, filed in
the above referenced docket a prior notice pursuant to Section 157.205
and 157.216 of the Federal Energy Regulatory Commission's regulations
under the Natural Gas Act, requesting authorization to abandon an
existing 6-inch supply lateral extending from

Galveston Area Block 223 to Galveston Block Area 240 and an existing
12-inch supply lateral extending from Galveston Area Block 255,
Platform ``A,'' to Galveston Area Block 239 and appurtenant metering
facilities, all in Federal offshore waters, offshore Texas. Transco
proposes to abandon these facilities under authorities granted by its
blanket certificate issued in Docket No. CP82-426-000. The proposed
abandonments will have no impact on Transco's existing customers. The
estimated cost for the project is approximately $2.6 million, all as
more fully set forth in the request which is on file with the
Commission and open to public inspection.
    In addition to publishing the full text of this document in the
Federal Register, the Commission provides all interested persons an
opportunity to view and/or print the contents of this document via the
internet through the Commission's Home Page (http://ferc.gov) using the
``eLibrary'' link. Enter the docket number excluding the last three
digits in the docket number field to access the document. At this time,
the Commission has suspended access to the Commission's Public
Reference Room, due to the proclamation declaring a National Emergency
concerning the Novel Coronavirus Disease (COVID-19), issued by the
President on March 13, 2020. For assistance, contact the Federal Energy
Regulatory Commission at<EMAIL_ADDRESS>or call toll-free,
(886) 208-3676 or TYY,<PHONE_NUMBER>.
    Any questions concerning this application should be directed to
Jordan Kirwin, Director, Rates & Regulatory, Transcontinental Gas Pipe
Line Company, LLC, P.O. Box 1396, Houston, Texas 77251;<PHONE_NUMBER>,
<EMAIL_ADDRESS>
Public Participation

    There are three ways to become involved in the Commission's review
of this project: you can file a protest to the project, you can file a
motion to intervene in the proceeding, and you can file comments on the
project. There is no fee or cost for filing protests, motions to
intervene, or comments. The deadline for filing protests, motions to
intervene, and comments is 5:00 p.m. Eastern Time on March 23, 2021.
How to file protests, motions to intervene, and comments is explained
below.

Protests

    Pursuant to section 157.205 of the Commission's regulations under
the NGA,\1\ any person \2\ or the Commission's staff may file a protest
to the request. If no protest is filed within the time allowed or if a
protest is filed and then withdrawn within 30 days after the allowed
time for filing a protest, the proposed activity shall be deemed to be
authorized effective the day after the time allowed for protest. If a
protest is filed and not withdrawn within 30 days after the time
allowed for filing a protest, the instant request for authorization
will be considered by the Commission.
---------------------------------------------------------------------------

    \1\ 18 CFR 157.205.
    \2\ Persons include individuals, organizations, businesses,
municipalities, and other entities. 18 CFR 385.102(d).
---------------------------------------------------------------------------

    Protests must comply with the requirements specified in section
157.205(e) of the Commission's regulations,\3\ and must be submitted by
the protest deadline, which is March 23, 2021. A protest may also serve
as a motion to intervene so long as the protestor states it also seeks
to be an intervenor.
---------------------------------------------------------------------------

    \3\ 18 CFR 157.205(e).
---------------------------------------------------------------------------

Interventions

    Any person has the option to file a motion to intervene in this
proceeding. Only intervenors have the right to request rehearing of
Commission orders issued in this proceeding and to subsequently
challenge the Commission's orders in the U.S. Circuit Courts of Appeal.
    To intervene, you must submit a motion to intervene to the
Commission in accordance with Rule 214 of the Commission's Rules of
Practice and Procedure \4\ and the regulations under the NGA \5\ by the
intervention deadline for the project, which is March 23, 2021. As
described further in Rule 214, your motion to intervene must state, to
the extent known, your position regarding the proceeding, as well as
your interest in the proceeding. For an individual, this could include
your status as a landowner, ratepayer, resident of an impacted
community, or recreationist. You do not need to have property directly
impacted by the project in order to intervene. For more information
about motions to intervene, refer to the FERC website at https://www.ferc.gov/resources/guides/how-to/intervene.asp.
---------------------------------------------------------------------------

    \4\ 18 CFR 385.214.
    \5\ 18 CFR 157.10.
---------------------------------------------------------------------------

    All timely, unopposed motions to intervene are automatically
granted by operation of Rule 214(c)(1). Motions to intervene that are
filed after the intervention deadline are untimely and may be denied.
Any late-filed motion to intervene must show good cause for being late
and must explain why the time limitation should be waived and provide
justification by reference to factors set forth in Rule 214(d) of the
Commission's Rules and Regulations. A person obtaining party status
will be placed on the service list maintained by the Secretary of the
Commission and will receive copies (paper or electronic) of all
documents filed by the applicant and by all other parties.

Comments

    Any person wishing to comment on the project may do so. The
Commission considers all comments received about the project in
determining the appropriate action to be taken. To ensure that your
comments are timely and properly recorded, please submit your comments
on or before March 23, 2021. The filing of a comment alone will not
serve to make the filer a party to the proceeding. To become a party,
you must intervene in the proceeding.

How To File Protests, Interventions, and Comments

    There are two ways to submit protests, motions to intervene, and
comments. In both instances, please reference the Project docket number
CP21-26-000 in your submission.
    (1) You may file your protest, motion to intervene, and comments by
using the Commission's eFiling feature, which is located on the
Commission's website (www.ferc.gov) under the link to Documents and
Filings. New eFiling users must first create an account by clicking on
``eRegister.'' You will be asked to select the type of filing you are
making; first select General'' and then select ``Protest'',
``Intervention'', or ``Comment on a Filing''; or \6\
---------------------------------------------------------------------------

    \6\ Additionally, you may file your comments electronically by
using the eComment feature, which is located on the Commission's
website at www.ferc.gov under the link to Documents and Filings.
Using eComment is an easy method for interested persons to submit
brief, text-only comments on a project.
---------------------------------------------------------------------------

    (2) You can file a paper copy of your submission by mailing it to
the address below.\7\ Your submission must reference the Project docket
number CP21-26-000. Kimberly D. Bose, Secretary, Federal Energy
Regulatory Commission, 888 First Street NE, Washington, DC 20426.
---------------------------------------------------------------------------

    \7\ Hand-delivered submissions in docketed proceedings should be
delivered to Health and Human Services, 12225 Wilkins Avenue,
Rockville, Maryland 20852.
---------------------------------------------------------------------------

    The Commission encourages electronic filing of submissions (option
1 above) and has eFiling staff available to assist you at (202) 502-
8258 or [email protected]
    Protests and motions to intervene must be served on the applicant
either

by mail or email (with a link to the document) at: P.O. Box 1396,
Houston, Texas 77251<EMAIL_ADDRESS>Any subsequent
submissions by an intervenor must be served on the applicant and all
other parties to the proceeding. Contact information for parties can be
downloaded from the service list at the eService link on FERC Online.

Tracking the Proceeding

    Throughout the proceeding, additional information about the project
will be available from the Commission's Office of External Affairs, at
(866) 208-FERC, or on the FERC website at www.ferc.gov using the
``eLibrary'' link as described above. The eLibrary link also provides
access to the texts of all formal documents issued by the Commission,
such as orders, notices, and rulemakings.
    In addition, the Commission offers a free service called
eSubscription which allows you to keep track of all formal issuances
and submittals in specific dockets. This can reduce the amount of time
you spend researching proceedings by automatically providing you with
notification of these filings, document summaries, and direct links to
the documents. For more information and to register, go to
www.ferc.gov/docs-filing/esubscription.asp.

    Dated: January 22, 2021.
Kimberly D. Bose,
Secretary.
[FR Doc. 2021-01875 Filed 1-27-21; 8:45 am]
BILLING CODE 6717-01-P


UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON D.C., 20460

OFFICE OF CHEMICAL SAFETY AND POLLUTION' PREVENTlON

 .

PC Code: 129112

DP Barcodes: 413801

MEMORANDUM	January 28, 2014

SUBJECT: 	Trifloxystrobin: Drinking Water Exposure Assessment in Support of a Proposed

New Use on Dry Peas, Chickpeas, and Lentils (Reg. Nos. 264-776 (technical) and

264-1055).

TO: 	Christine Olinger, Branch Chief

Nancy Tsaur, Chemist

Risk Assessment Branch 3

Health Effects Division (7509P)

Cynthia Giles-Parker, Branch Chief Tony Kish, Product Manager Dominic Schuler, Reviewer Registration  Division (7505P)

FROM: 	Melanie Biscoe, Physical Scientist

Environmental  Risk Branch 3

Environmental Fate and Effects Division

THROUGH:

DanaSpatz,BranchChief 	h_	1/2."11Z.,.lt

Environmental Risk Branch 3 	'-

Environmental Fate and Effects Division (7507P)

Executive Summary

This drinking water assessment was conducted in response to Bayer Corporation's request to register tri:floxystrobin for use on dry peas, chickpeas, and lentils.  When considering this request, the Environmental  Fate and Effects Division (EFED) determined  that a currently registered use, turf,  continues to have the highest annual use rate (1.33 lb a.i./acre) of all the proposed and existing uses oftritloxystrobin, and would result in the highest estimated drinking water concentrations (EDWCs).  This DWA takes into account tri:floxystrobin plus a major

degradate, CGA-321113, as recommended by the Metabolism Assessment Review Committee

(MARC)1 using the total toxic residue (TTR) approach.

Surface water and groundwater EDWCs for turf, using the TTR approach, were previously developed in a 2010 drinking water assessment (D378919).2  Since the 2010 assessment, EFED has implemented the use of the PRZM-GW model to estimate groundwater concentrations. Therefore, this assessment relies on surface water EDWCs from the 2010 DWA and presents updated Tier I EDWCs for groundwater using the PRZM-GW model.  Maximum surface water EDWCs from the 2010 DWA and maximum groundwater EDWCs developed for this assessment are reported in Table 1.

The Tier I groundwater EDWCs for trifloxystrobin total toxic residues in this assessment are greater than the surface water EDWCs from the 2010 DWA. The highest estimated peak (acute) concentration of total toxic residues in groundwater is 427 μ?g/L, and the highest estimated (chronic) concentration in groundwater is 365 μ?g/L (Table 1).  EFED recommends using these values for the human health dietary risk assessment.

Table 1. Maximum estimated drinking water concentrations (EDWCs) of total toxic residues in parts per billion (μ?g/L) resulting from applications of trifloxystrobin on turf at an annual application rate of 1.33 lb a.i./acre

1Drinking Water Assessment for Tolerance Petition for New Uses of Trifloxystrobin in Trifloxystrobin Flowable

Fungicide [EPA Reg. No. 264-989].  D378919.

Background

Trifloxystrobin [E,E)-alpha-(methoxyimino)-2-[[[[1-[3-(trifluoromethyl) phenyl] ethylidene]amino]oxy]methyl]-methyl ester] is an active ingredient used in several agricultural fungicide products used to control fungal pathogens on various grain, vegetable, fruit, nut crops, ornamental plants, and turf.  It is used via aerial, chemigation and ground applications, as well as in seed treatment.  Trifloxystrobin is classified as an oximinoacetate fungicide in the strobilurin class.

                                                     1 Trifloxystrobin.  Results of HED Metabolism Assessment Review Committee Meeting held 6/15/99.  DP Barcode

257835.  July 13, 1999.

2 Drinking Water Assessment for Tolerance Petition for New Uses of Trifloxystrobin in Trifloxystrobin Flowable

Fungicide [EPA Reg. No. 264-989].  D378919.

The registrant, Bayer Corporation, requested new uses of trifloxystrobin on dry peas, chickpeas, and lentils.  The proposed single application rate for these new uses is 12.0 fluid ounces of product per acre, or 0.12 lb ai/acre.  The maximum annual application rate is 0.24 lb ai/acre. The minimum re-application interval for these proposed uses is 10 days.

The currently registered turf use has the highest single and annual application rates of all existing aerial, chemigation and ground uses of trifloxystrobin.  The turf use has a single application rate over two times higher than the proposed new uses on chickpea, dry peas and lentils, and an annual application rate more than four times higher than these proposed new uses.  It is therefore expected that EDWCs calculated for the turf use would be protective of the proposed new uses

on chickpea, dry peas, and lentils.  Table 2 provides additional details concerning the proposed uses as compared to the turf use.

The turf use was assessed most recently in 2010 using the TTR approach (D378919), which considered drinking water exposures of parent trifloxystrobin and its free acid degradate CGA-

321113.  The EDWCs from the 2010 assessment were 29

Table 2. Comparison of Proposed Chickpea, Dry Peas, and Lentils Uses to Existing Turf

                                                                                Uses.

Use Site

Application

MethodMaximum

Single Application RateMaximum

Annual Application Rate

Maximum Applications Per Year1

Minimum Reapplication Intervallb ai/acrelb ai/acredaysProposed Use

Chickpea, Dry peas, LentilsAerial, Ground, and Chemigation equipment

0.12

0.24

2

10Existing UseTurf,

Residential, Commercial, or IndustrialAerial, Ground

Sprayer, Hand-held or Backpack Sprayer

0.34

1.08

3

14

Turf, golf courseAerial, Ground

Sprayer, Hand-held or Backpack Sprayer

0.34

1.08

3

14Ground Sprayer, Hand-Held or Backpack Sprayer

0.31

1.33

6 (4.3)

14

                                                     3 Drinking Water Assessment for Tolerance Petition for New Uses of Trifloxystrobin in Trifloxystrobin Flowable

Fungicide [EPA Reg. No. 264-989].  D378919.

Environmental Fate and Transport Characterization

The environmental fate and physiochemical properties of trifloxystrobin and its major

degradation product CGA-321113 are summarized in Table 3 and Table 4, respectively. Table 4

also includes the aerobic soil metabolism half-life for the total toxic residues.  Chemical structures for trifloxystrobin and CGA-321113 are available in Appendix 1.

Parent: Trifloxystrobin

Trifloxystrobin has a low solubility (0.61 mg/L @ pH 7) in water. The vapor pressure is 2.55 x

10-8 torr at 25

Trifloxystrobin is non-persistent in soil. Laboratory studies indicate that biotransformation is an important route of trifloxystrobin transformation in aerobic soil. Trifloxystrobin degraded rapidly in aerobic soils with half-lives ranging between 0.41 and 0.91 days. In aerobic soils the major degradate is CGA-321113. Photodegradation in soil results in the isomerization and subsequent formation of CGA-321113. The photo-induced isomerization half-life (t1/2) was 2.1 days on soils. Based upon the soil organic carbon coefficient, Koc (median Koc =2709 mL/goc), trifloxystrobin would fall into the slightly mobile class4.

Laboratory studies indicate that trifloxystrobin is also not persistent in water. Hydrolysis of trifloxystrobin is dependent on pH; while trifloxystrobin is stable to hydrolysis under acidic conditions (pH 4), it readily hydrolyzes to CGA-321113 in alkaline conditions (t1/2 = 55.2 days at pH 7 and 0.83 days at pH 9). In the aquatic environment, the photo-induced isomerization half- life (t1/2) was 14.8 days. In an aerobic aquatic sediment system, the major transformation product was CGA-321113.

Trifloxystrobin demonstrated a biphasic degradation pattern in field dissipation studies

conducted in California, New York, and Georgia.  For the first degradation phase, trifloxystrobin half-life values ranged from 1.9 to 24 days.  In the second degradation phase, half-life values ranged from 6.5 days to 4 months.

Degradate of Concern: CGA-321113

CGA-321113 is the major transformation product identified in trifloxystrobin soil metabolism studies.  Fate studies indicate that CGA-321113 is quite persistent in soil (DT50 250 to 350 days) and aquatic environments (DT50 = 289 days).  It is stable to hydrolysis and metabolism;

therefore, CGA-321113 is expected to degrade at a slower rate than trifloxystrobin in both soil

and water.  The aqueous solubility for CGA-321113 (30.9 mg/L) is three orders of magnitude higher than the aqueous solubility for trifloxystrobin. CGA-321113 is a carboxylic acid, and therefore being anionic, is expected to be more mobile than parent trifloxystrobin. The

adsorption/desorption mobility classification of CGA-321113 is mobile to moderately mobile5. Because of its persistence and mobility, CGA-321113 has greater potential for leaching than trifloxystrobin.

In contrast to laboratory data, CGA-321113 was not detected above 0.02 percent of the applied amount in leachates from a field lysimeter study. In field dissipation studies conducted in Georgia, California, and New York, under bare ground and cropped conditions, CGA-321113 concentrations reached or were slightly above the Limit of Quantitation of 10 30-36 inch soil segments.

Table 3. Chemical Properties and Environmental Fate Parameters For Trifloxystrobin.

a USEPA Fact Sheet reports 3.4 x 10-6 torr (@25 b PMRA Reg2004-03 and Trifloxystrobin (213) report 3.4 x 10-6 Pa @ (@25

Table 4. Chemical Properties and Environmental Fate Parameters For CGA-321113 and Residues of Concern (trifloxystrobin + degradate CGA-321113).

 Parameter Values1 Source CGA-321113 Molecular Formula C19H17F3N2O4 MRID 44496801 Molecular Weight 394.35 MRID 44496801 Solubility @ 20 ◦?C 30.9 mg/L MRID 44496816 Vapor Pressure 7.5 x 10-08 mm Hg @ 20 ◦?C MRID 44496801 Henry’s Constant 1.26 x 10-09   atm m3 mol-1 Hydrolysis Half-life Stable MRID 44496727 Aquatic Photolysis Half-life Stable MRID 44496727 Photolysis on soil Half-life Stable MRID 44496727 Aerobic Aquatic Metabolism Half- life Stable MRID 44496734 Anaerobic Aquatic Metabolism

Half-lifeStableMRID 44496733Organic Carbon Partition

Coefficient (Koc) (mL/g)127, 235, 130, 48, and 80

mean 124.0 mL/goc

median 127 mL/goc

Coef. Determination (r2) = 0.89 for

Kf   vs. omMRID 44496801Soil Partition Coefficient (Kf) (mL/g)Kf (texture class)

4.0	Loam (5.4% om)

1.9	Sand

3.2	Clay loam

0.28	Sandy loam (1% om)

0.65	Sandy loam

mean = 2.0 mL/g

[1/n = 0.81 to 0.85]MRID 44496801Persistence for Residues of Concern (parent trifloxystrobin + CGA-321113)(DP D309489 see Table 9)[Residues of Concern]:

Aerobic Soil Metabolism Half-life254.8 days

271.3 days

199.7 days

282.75 days

(90th percent upper bound on mean) Median = 254.8 daysMRID 44496732

MRID 44496730

MRID 44496731Models and Model Scenarios Used

Detailed descriptions, documentation, and links for running the exposure models used in this assessment may be found at     HYPERLINK http://www.epa.gov/oppefed1/models/water/index.htm   http://www.epa.gov/oppefed1/models/water/index.htm.

Groundwater EDWCs for total toxic residues of trifloxystrobin resulting from the turf use were derived with PRZM-GW (Pesticide Root Zone Model for Groundwater, version 1.0, August 31,

2012), using the GW-GUI (Graphical User Interface, version 1.0, August 31, 2012).  EDWCs for the Screening Concentration in Groundwater model were calculated in a 2010 DWA and are reported in this assessment (SCI-GROW v2.3, compiled 08/08/03).6   Surface water EDWCs

were derived using PRZM/EXAMS as described in the 2010 DWA.

Model Input Parameters

The model input parameters for PRZM-GW are summarized in Table 4.  Model input values were prepared following EFED input guidance7,8.

For each PRZM-GW scenario, EDWCs were calculated for each year in a 30-year simulation where trifloxystrobin was applied at the maximum label rate for 30 consecutive years.  The initial application date was assumed to be the date of emergence for the PRZM-GW scenario used.  Figure 1 is the PRZM-GW User Interface that shows the model inputs for the trifloxystrobin total toxic residues and illustrates how multiple applications were included in the modeling.

Table 4. Input Values Used to Model Total Toxic Residue EDWCs in Groundwater for the

Trifloxystrobin Turf Use.

Model Input Parameter

PRZM-GW Input Value and Unit

Source/Comments

Maximum Application Rate

0.347 kg a.i./ha for the first four applications, 0.101 kg a.i./ha for the fifth application for an annual application rate of 1.489 kg a.i./haLabel; Corresponds to four applications of 0.31 lb a.i./acre and a fifth application of 0.9 lb a.i./acre

for an annual application rate of

1.33 lb a.i./acre.

Maximum Number of Applications

5

The label indicates 6 applications may be made, but not at the maximum single application rate.

                                                     6 Drinking Water Assessment for Tolerance Petition for New Uses of Trifloxystrobin in Trifloxystrobin Flowable

Fungicide [EPA Reg. No. 264-989].  D378919.

7 Parameters are selected as per Guidance for Selecting Input Parameters in Modeling the Environmental Fate and

Transport of Pesticides; Version 2.1, October 22, 2009.

8 Baris, R.; Barrett, M.; Bohaty, R.; Echeverria, M.; Kennedy, I.; Malis, G.; Wolf, J.; Young, D. PRZM-GW Input

Parameter Guidance; Health Canada, U.S. Environmental Protection Agency, October 12, 2012.

Model Input Parameter

PRZM-GW Input Value and Unit

Source/Comments

Method of Application

CAM 1, Bare Ground

Label

Date of Initial Application

120 days post-emergence

Emergence dates are specified in each PRZM-GW scenario.

Minimum Interval between

Applications

14 days

Label

Soil Partition Coefficient Koc

(CGA-321113)

124 mL/goc

(mean)

MRID 44496801

Hydrolysis Half-Life

(CGA-321113)

Stable

MRID 44496727

Aerobic Soil Metabolism Half-Life

(parent trifloxystrobin + CGA-

321113)

282.75 days

(90th percent upper bound on mean)

MRID 44496732

MRID 44496730

MRID 44496731Figure 1. Trifloxystrobin - Example of PRZM-GW User Interface and Inputs for Foliar

Applications to Turf.

Modeling Results

Table 5 reports the EDWCs calculated for each PRZM-GW (i.e., groundwater) scenario for applications at 120 days post-emergence. EDWCs calculated for 0- and 60-days post-emergence were also calculated and yielded EDWCs approximately 10-30 427

EDWCs for the turf use were calculated using SCI-GROW in the 2010 DWA, which resulted in acute and chronic EDWC of 5.87

EFED recommends using the maximum peak and post-breakthrough average concentrations from the 30-year PRZM-GW simulation for the Wisconsin corn scenario for human health risk assessment (i.e., 427 and 365 μ?g/L). and are not expected to be greater than

Table 5. Tier I PRZM-GW Total Toxic Residue Estimated Drinking Water Concentrations

(EDWCs) for 30 Years for the Trifloxystrobin Turf Use.

Scenario

Peak (

Throughputs*First Application 120 Days Post‐?EmergenceFL Citrus24118712508.8DMV Corn25820212398.8FL Potato554928623.8GA Peanuts1139630233.6NC Cotton25021620565.3WI Corn42736528483.8*Throughputs are the estimated pore volumes/retardation factors that occur in the simulation.

                                                     9 Drinking Water Assessment for Tolerance Petition for New Uses of Trifloxystrobin in Trifloxystrobin Flowable

Fungicide [EPA Reg. No. 264-989].  D378919.

Figure 2. PRZM-GW Wisconsin Corn Scenario Time Series Graph for 30 Years

Trifloxystrobin Application to Turf (ppb is equivalent to

Tier I PRZM-GW Modeling Assumptions

In estimating pesticide concentrations in water resources, OPP uses a tiered screening approach involving a combination of models and monitoring data. The intent of the screening approach is to estimate pesticide concentration in water from sites that are highly vulnerable to runoff or leaching so that the program can be confident that any pesticide that passes the screening tiers poses a low possibility of harming human health, wildlife, or the environment. Failing a tier, however, does not necessarily mean the chemical is likely to cause health or environmental problems, but rather that there is a need to move to a higher tier and conduct a more refined assessment. This tiered modeling system is designed to provide a thorough analysis of each pesticide, while at the same time focus OPP's efforts on those pesticides that pose the greatest potential risk.

In this assessment, PRZM-GW is used as a Tier-1 screen.  In other words, the modeling conducted for this assessment preserves default conservative assumptions in the PRZM-GW model.  As such, Tier 1 PRZM-GW modeling is expected to result in conservative groundwater EDWCs that would rarely, if ever, occur in the environment.

Depending on the Tier I results, Tier II (or “refined”) EDWCs may be modeled to take into account usage data, well setback requirements, additional fate inputs, and an exposure duration specific to the exposure duration of concern for humans.  A more representative scenario may also be developed as part of Tier II EDWC modeling.  This assessment has not calculated Tier II EDWCs using PRZM-GW, and thus does not consider trifloxystrobin usage data, well setbacks, additional fate inputs, specific exposure durations, or new scenario development.  For more information on potential Tier II refinements in PRZM-GW modeling, see     HYPERLINK http://www.epa.gov/oppefed1/models/water/przm_gw/wqtt_przm_gw_guidance.h tm)   http://www.epa.gov/oppefed1/models/water/przm_gw/wqtt_przm_gw_guidance.h tm).

The default PRZM-GW assumptions used in calculating Tier I groundwater EDWCs for trifloxystrobin total toxic residues include the following:

?	Trifloxystrobin is used at the maximum labeled rate for 30 consecutive years.

?	There are no well setbacks.

?	Removal of the pesticide via runoff or erosion is negligible.

?	The saturated zone is a shallow (<100 feet), unconfined aquifer with a water table depth that corresponds to its respective scenario location.

?	The well screen extends from the aquifer surface to 1 meter below the aquifer surface.

?	The pesticide undergoes aerobic soil metabolism in the top 10 cm of soil; the aerobic soil metabolism rate declines linearly to 1 meter below the soil surface, below which only abiotic degradation processes (i.e., hydrolysis) occur.

These assumptions are designed to introduce a high level of protection into the modeling results.

Monitoring Data

Surface water and groundwater data from one state and three nationwide pesticide monitoring programs were reviewed to provide additional context concerning the potential presence of trifloxystrobin in drinking water resources.  These water monitoring programs do not target sample collection to peak use locations or application times for particular pesticides, nor do they target sample collection to high precipitation events (i.e., high-runoff events).  Additionally, the sampling frequency in these monitoring programs was not designed to capture peak concentrations.  Therefore, the monitoring data reported by these programs may not represent the highest concentrations in drinking water source water, and are considered qualitative information for the purposes of this drinking water assessment.

 USGS-EPA Pilot Reservoir Monitoring Program - Trifloxystrobin and CGA-321113 data were not analyzed as part of this program.

 USGS National Water-Quality Assessment (NAWQA) Program Data - Trifloxystrobin data were available from USGS NAWQA surface water and sediment data.  Surface water detections were from Cobb and Coweta counties in Georgia in 2010 (2 samples with detections less than 4.7 ng/L), Cameron County in Texas in 2013 (1 sample with a detection less than 2 ng/L), and San Joaquin and Sacramento Counties in California in 2012 (11 samples with detections less than 4.7 ng/L).  In Georgia’s Cobb, Coweta, and Sumter counties, sediment samples taken from 2010 to

2011 had trifloxystrobin detections less than 1.4 ug/kg.  Trifloxystrobin was not detected in groundwater.  NAWQA has not analyzed surface water or groundwater samples for CGA-

321113.  NAWQA program data are available at     HYPERLINK http://infotrek.er.usgs.gov/nawqa_queries/index.jsp   http://infotrek.er.usgs.gov/nawqa_queries/index.jsp.

 California Surface Water Monitoring Program Data - The California Surface Water Monitoring Program represents pesticide occurrence data for surface waters in the Sacramento Valley, San Joaquin Valley, and other locations in the state. The California surface water and groundwater monitoring data included a total of 43 surface water detections for trifloxystrobin, all below the level of quantitation (LOQs of 0.02 to 0.05 μ?g/L) from Colusa, Sutter, Yolo and Yuba counties from 2006 to 2008.  The California Surface Water Monitoring Program has not analyzed surface water or groundwater for CGA-321113.  California Surface Water Monitoring Program data are available at     HYPERLINK http://www.cdpr.ca.gov/docs/emon/surfwtr/surfdata.htm   http://www.cdpr.ca.gov/docs/emon/surfwtr/surfdata.htm.

 Pesticide Data Program (PDP) Data - The PDP drinking water monitoring project provides non- targeted pesticide occurrence data in raw water, finished water (treated/tap), and groundwater in the United States.  The PDP has not analyzed surface water or groundwater for detections of trifloxystrobin or CGA-321113.  PDP data are available at     HYPERLINK http://www.ams.usda.gov/AMSv1.0/pdp   http://www.ams.usda.gov/AMSv1.0/pdp.

Appendix 1.  Chemical Structures for Trifloxystrobin and CGA-321113

 Trifloxystrobin

 CGA-321113


[Federal Register Volume 79, Number 208 (Tuesday, October 28, 2014)]
[Notices]
[Pages 64201-64202]
[FR Doc No: 2014-25534]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-P-0979]

Determination That DIAMOX (Acetazolamide) Intravenous, 500
Milligrams Base/Vial, and DIAMOX (Acetazolamide) Tablets, 125
Milligrams and 250 Milligrams, Were Not Withdrawn From Sale for Reasons
of Safety or Effectiveness

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) has determined that
DIAMOX (acetazolamide) intravenous, 500 milligrams (mg) base/vial, and
DIAMOX (acetazolamide) tablets, 125 mg and 250 mg, were not withdrawn
from sale for reasons of safety or effectiveness. This determination
means that FDA will not begin procedures to withdraw approval of
abbreviated new drug applications (ANDAs) that refer to these drug
products, and it will allow FDA to continue to approve ANDAs that refer
to these products, if all other legal and regulatory requirements are
met.

FOR FURTHER INFORMATION CONTACT: Ayako Sato, Center for Drug Evaluation
and Research, Food and Drug Administration, 10903 New Hampshire Ave.,
Bldg. 51, Rm. 6228, Silver Spring, MD 20993-0002,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: In 1984, Congress enacted the Drug Price
Competition and Patent Term Restoration Act of 1984 (Pub. L. 98-417)
(the 1984 amendments), which authorized the approval of duplicate
versions of drug products under an ANDA procedure. ANDA applicants
must, with certain exceptions, show that the drug for which they are
seeking approval contains the same active ingredient in the same
strength and dosage form as the ``listed drug,'' which is a version of
the drug that was previously approved. ANDA applicants do not have to
repeat the extensive clinical testing otherwise necessary to gain
approval of a new drug application (NDA).
    The 1984 amendments include what is now section 505(j)(7) of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(j)(7)), which
requires FDA to publish a list of all approved drugs. FDA publishes
this list as part of the ``Approved Drug Products With Therapeutic
Equivalence Evaluations,'' which is known generally as the ``Orange
Book.'' Under FDA regulations, drugs are removed from the list if the
Agency withdraws or suspends approval of the drug's NDA or ANDA for
reasons of safety or effectiveness or if FDA determines that the listed
drug was withdrawn from sale for reasons of safety or effectiveness
(Sec.  314.162 (21 CFR 314.162)).
    A person may petition the Agency to determine, or the Agency may
determine on its own initiative, whether a listed drug was withdrawn
from sale for reasons of safety or effectiveness. This determination
may be made at any time after the drug has been withdrawn from sale,
but must be made prior to approving an ANDA that refers to the listed
drug (Sec.  314.161 (21 CFR 314.161)). FDA may not approve an ANDA that
does not refer to a listed drug.
    DIAMOX (acetazolamide) intravenous, 500 mg base/vial, is the
subject of NDA 009-388, held by Teva Branded Pharmaceutical Products
R&D, Inc., and initially approved on June 25, 1954. DIAMOX
(acetazolamide) tablets, 125 mg and 250 mg, are the subject of NDA 008-
943, held by Teva Branded Pharmaceutical Products R&D, Inc., and
initially approved on July 27, 1953. DIAMOX (acetazolamide)
intravenous, 500 mg base/vial, and DIAMOX (acetazolamide) tablets, 125
mg and 250 mg, are indicated for adjunctive treatment of: Edema due to
congestive heart failure; drug-induced edema; centrencephalic
epilepsies (petit mal, unlocalized seizures); and chronic simple (open-
angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-
closure glaucoma where delay of surgery is desired in order to lower
intraocular pressure. DIAMOX (acetazolamide) intravenous, 500 mg base/
vial, and DIAMOX (acetazolamide) tablets, 125 mg and 250 mg, are also
indicated for the prevention or amelioration of symptoms associated
with acute mountain sickness in climbers attempting rapid ascent and in
those who are very susceptible to acute mountain sickness despite
gradual ascent.
    DIAMOX (acetazolamide) intravenous, 500 mg base/vial, and DIAMOX
(acetazolamide) tablets, 125 mg and 250 mg, are currently listed in the
``Discontinued Drug Product List'' section of the Orange Book.
    Emcure Pharmaceuticals USA, Inc., submitted a citizen petition
dated July 3, 2014 (Docket No. FDA-2014-P-0979), under 21 CFR 10.30,
requesting that the Agency determine that DIAMOX (acetazolamide)
intravenous, 500 mg base/vial, was discontinued for reasons unrelated
to safety and effectiveness. Although the citizen petition did not
address DIAMOX (acetazolamide) tablets, 125 mg and 250 mg, since those
products have also been discontinued, on our own initiative, we
therefore determined whether DIAMOX (acetazolamide) tablets, 125 mg and
250 mg, were withdrawn for safety or effectiveness reasons.
    After considering the citizen petition and reviewing Agency
records, FDA has determined under Sec.  314.161 that DIAMOX
(acetazolamide) intravenous, 500 mg base/vial, and DIAMOX
(acetazolamide) tablets, 125 mg and 250 mg, were not withdrawn for
reasons of safety or effectiveness. The petitioner has identified no
data or other information suggesting that DIAMOX (acetazolamide)
intravenous, 500 mg base/vial, was withdrawn for reasons of safety or
effectiveness. We have carefully reviewed our files for records
concerning the withdrawal of DIAMOX (acetazolamide) intravenous, 500 mg
base/vial, and DIAMOX (acetazolamide) tablets, 125 mg and 250 mg from
sale. We have also independently evaluated relevant literature and data
for possible postmarketing adverse events and have found no information
that would indicate that these products were

withdrawn from sale for reasons of safety or effectiveness.
    Accordingly, the Agency will continue to list DIAMOX
(acetazolamide) intravenous, 500 mg base/vial, and DIAMOX
(acetazolamide) tablets, 125 mg and 250 mg, in the ``Discontinued Drug
Product List'' section of the Orange Book. The ``Discontinued Drug
Product List'' delineates, among other items, drug products that have
been discontinued from marketing for reasons other than safety or
effectiveness. FDA will not begin procedures to withdraw approval of
ANDAs that refer to DIAMOX (acetazolamide) intravenous, 500 mg base/
vial, and DIAMOX (acetazolamide) tablets, 125 mg and 250 mg. Additional
ANDAs that refer to these products may also be approved by the Agency
as long as they meet all other legal and regulatory requirements for
the approval of ANDAs. If FDA determines that labeling for these drug
products should be revised to meet current standards, the Agency will
advise ANDA applicants to submit such labeling.

    Dated: October 21, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-25534 Filed 10-27-14; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 88, Number 55 (Wednesday, March 22, 2023)]
[Notices]
[Page 17214]
[FR Doc No: 2023-05858]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. EL23-31-000]

Commonwealth Edison Company; Notice of Institution of Section 206
Proceeding and Refund Effective Date

    On March 16, 2023, the Commission issued an order in Docket No.
EL23-31-000, pursuant to section 206 of the Federal Power Act (FPA), 16
U.S.C. 824e, instituting an investigation into whether Commonwealth
Edison Company's formula rate protocols are unjust, unreasonable,
unduly discriminatory or preferential, or otherwise unlawful.
Commonwealth Edison Company, 182 FERC ] 61,156 (2023).
    The refund effective date in Docket No. EL23-31-000, established
pursuant to section 206(b) of the FPA, will be the date of publication
of this notice in the Federal Register.
    Any interested person desiring to be heard in Docket No. EL23-31-
000 must file a notice of intervention or motion to intervene, as
appropriate, with the Federal Energy Regulatory Commission, in
accordance with Rule 214 of the Commission's Rules of Practice and
Procedure, 18 CFR 385.214 (2022), within 21 days of the date of
issuance of the order.
    In addition to publishing the full text of this document in the
Federal Register, the Commission provides all interested persons an
opportunity to view and/or print the contents of this document via the
internet through the Commission's Home Page (http://www.ferc.gov) using
the ``eLibrary'' link. Enter the docket number excluding the last three
digits in the docket number field to access the document. At this time,
the Commission has suspended access to the Commission's Public
Reference Room, due to the proclamation declaring a National Emergency
concerning the Novel Coronavirus Disease (COVID-19), issued by the
President on March 13, 2020. For assistance, contact FERC at
[email protected] or call toll-free,<PHONE_NUMBER> or TYY,
(202) 502-8659.
    The Commission strongly encourages electronic filings of comments,
protests and interventions in lieu of paper using the ``eFile'' link at
http://www.ferc.gov. In lieu of electronic filing, you may submit a
paper copy. Submissions sent via the U.S. Postal Service must be
addressed to: Kimberly D. Bose, Secretary, Federal Energy Regulatory
Commission, 888 First Street NE, Room 1A, Washington, DC 20426.
Submissions sent via any other carrier must be addressed to: Kimberly
D. Bose, Secretary, Federal Energy Regulatory Commission, 12225 Wilkins
Avenue, Rockville, Maryland 20852.

    Dated: March 16, 2023.
Debbie-Anne A. Reese,
Deputy Secretary.
[FR Doc. 2023-05858 Filed 3-21-23; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register: December 12, 2008 (Volume 73, Number 240)]
[Notices]
[Page 75793-75794]
[DOCID:fr12de08-126]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2008-0336]

Agency Information Collection Activities; New Information
Collection: Annual Commercial Vehicle Driver Survey: Work and
Compensation

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Paperwork Reduction Act of 1995, FMCSA
announces its plan to submit the Information Collection Request (ICR)
described below to the Office of Management and Budget (OMB) for its
review and approval and invites public comment. The purpose of this
information collection is to acquire general information regarding the
commercial motor vehicle driving population and specific information on
driver work history, work scheduling, and compensation. This
information is needed in many different types of analyses conducted by
the FMCSA and would benefit the FMCSA in assessing the impacts of
proposed rules and the improvement of its safety programs.

DATES: We must receive your comments on or before February 10, 2009.

ADDRESSES: You may submit comments bearing the Federal Docket
Management System (FDMS) Docket Number FMCSA-2008-0336 using any of the
following methods:
     Federal eRulemaking Portal: Go to http://
www.regulations.gov. Follow the online instructions for submitting
comments.
     Mail: Docket Management Facility; U.S. Department of
Transportation, 1200 New Jersey Avenue, SE., West Building Ground
Floor, Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue, SE., Washington, DC 20590-0001 between 9 a.m.
and 5 p.m., e.t., Monday through Friday, except Federal holidays.
     Fax: 1-202-493-2251.

Each submission must include the Agency name and the docket number for
this Notice. Note that DOT posts all comments received without change
to http://www.regulations.gov, including any personal information
included in a comment. Please see the Privacy Act heading below.
    Docket: For access to the docket to read background documents or
comments, go to http://www.regulations.gov at any time or Room W12-140
on the ground level of the West Building, 1200 New Jersey Avenue, SE.,
Washington, DC 20590-0001 between 9 a.m. and 5 p.m., Monday through
Friday, except Federal holidays. The FDMS is available 24 hours each
day, 365 days each year. If you want acknowledgement that we received
your comments, please include a self-addressed, stamped envelope or
post card or print the acknowledgement page that appears after
submitting online.
    Privacy Act: Anyone may search the electronic form of all comments
received into any of our dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, etc.).
You may review the DOT's complete Privacy Act Statement in the Federal
Register on April 11, 2000 (65 FR 19476). This information is also
available at http://docketsinfo.dot.gov.

FOR FURTHER INFORMATION CONTACT: Dr. Mindy Shalaby, Economist, Analysis
Division, Office of Analysis, Research and Technology, Federal Motor
Carrier Safety Administration, 1200 New Jersey Ave., SE., Washington,
DC 20590. Telephone:<PHONE_NUMBER>; e-mail<EMAIL_ADDRESS>
Requests for additional information or copies of the information
collection instrument and instructions should be directed to Dr.
Michelle Yeh, Engineering Psychologist, Human Factors Division, Volpe
National Transportation Systems Center, 55 Broadway, Cambridge, MA
02124. Telephone:<PHONE_NUMBER>; e-mail<EMAIL_ADDRESS>Office
hours are from 9 a.m. to 5 p.m., Monday through Friday, except Federal
holidays.

SUPPLEMENTARY INFORMATION: Background: The Federal Motor Carrier Safety
Administration (FMCSA) needs a better understanding of the commercial
motor vehicle (CMV) driving population. Driver-related factors are an
important consideration in CMV crashes, but there is no central
nationwide source of information describing the population of drivers
operating CMVs in the United States (US). Estimates of the number of
commercial drivers and particular subsets of drivers (e.g., local,
short-haul, and long-haul) are needed and would benefit FMCSA in
assessing the impacts of proposed rules and the improvement of its
safety programs. In particular, information on driver work history,
work schedule, and compensation is needed in many different types of
analyses conducted by the FMCSA.

    Driver work history addresses how long a CMV driver has been
working in the industry, his/her level of experience, and his/her type
of experience. These items include questions regarding driver tenure
with his/her current employer and the number of past employers to
provide information regarding the driver turnover rate. Items also
collect information about driver training to understand how drivers
learned to operate their CMVs and the amount of training that is
ongoing in the industry. Driver work schedule examines the issue of how
much drivers work and the activities in which they are engaged when
they work (e.g., driving time, loading time, waiting time). FMCSA is
interested in understanding whether drivers' work schedules are tracked
and how they are tracked (e.g., with paper log books or Electronic On-
Board Recorders (EOBRs). Finally, driver compensation collects
information on how much drivers earn and how they are paid (e.g.,
salary, by hour, or by mile). This data will allow FMCSA to estimate an
average wage rate, which can be used to understand the cost imposed on
drivers by current and proposed regulations.
    The goals of this survey are to acquire general demographic
information regarding the commercial motor vehicle driving population,
and specific information on driver work history, work scheduling, and
compensation. Data for this project will be collected via driver
interviews. The results of the information collection will be
summarized in a report for the FMCSA and made available to the public.
    Title: Annual Commercial Vehicle Driver Survey: Work and
Compensation.
    OMB Control Number: 2126-XXXX.
    Type of Request: New collection.
    Respondents: Commercial motor vehicle drivers.
    Estimated Number of Respondents: 576 commercial motor vehicle
drivers.
    Estimated Time per Response: 15 minutes per response.
    Expiration Date: N/A.
    Frequency of Response: Once.
    Estimated Total Annual Burden: 144 hours [576 respondents x 15
minutes/60 minutes per response = 144].
    Public Comments Invited: You are asked to comment on any aspect of
this information collection, including: (1) Whether the proposed
collection is necessary for the performance of FMCSA's functions; (2)
the accuracy of the estimated burden; (3) ways for the FMCSA to enhance
the quality, usefulness, and clarity of the collected information; and
(4) ways that the burden could be minimized without reducing the
quality of the collected information. The agency will summarize or
include your comments in the request for OMB's clearance of this
information collection.

    Issued on: December 5, 2008.
Terry Shelton,
Associate Administrator for Research and Information Technology.
[FR Doc. E8-29414 Filed 12-11-08; 8:45 am]

BILLING CODE 4910-EX-P


Megawatt Daily, September 16, 2011 (paid subscription)

This is a copyrighted item provided to EPA’s contractor through a
single-user license.  Copyrighted material is not placed in the
electronic public docket.  It is available in hard copy form in the
official administrative record at EPA’s Region 6 office.  To view the
hard copy form at EPA’s Region 6 office, please contact Joe Kordzi at
214 -665-7186,  HYPERLINK<EMAIL_ADDRESS><EMAIL_ADDRESS>, to schedule an appointment.


[Federal Register: November 1, 2007 (Volume 72, Number 211)]
[Notices]
[Page 61919-61921]
[DOCID:fr01no07-89]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-56698; File No. SR-CHX-2007-23]

 Self-Regulatory Organizations; Chicago Stock Exchange, Inc.;
Notice of Filing of Proposed Rule Change to Allow the Exchange to Open
at 8:30 a.m.

October 24, 2007.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on October 2, 2007, the Chicago Stock Exchange, Inc. (``CHX'' or
``Exchange'') filed with

the Securities and Exchange Commission (``Commission'') the proposed
rule change as described in Items I, II and III below, which Items have
been substantially prepared by the CHX. The Commission is publishing
this notice to solicit comments on the proposed rule change from
interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The CHX proposes to amend its rules allow the CHX to open at 8:30
a.m., without regard to whether the primary market in a particular
security is open and to make other associated changes to its rules. The
text of this proposed rule change is available on the Exchange's Web
site at http://www.chx.com/content/Participant_Information/Rules_Filings.html
, at the CHX's Office of the Secretary, and at the

Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the CHX included statements
concerning the purpose of and basis for the proposed rule changes and
discussed any comments it received regarding the proposal. The text of
these statements may be examined at the places specified in Item IV
below. The CHX has prepared summaries, set forth in sections A, B and C
below, of the most significant aspects of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    Under existing rules, the Exchange generally opens for trading in a
security once the primary market has done so.\3\ If the primary market
announces that it will not open, or if the primary market has delayed
its opening for reasons other than a regulatory halt, the rules permit
two senior CHX officials to open the market.\4\
---------------------------------------------------------------------------

    \3\ See CHX Rules, Article 20, Rule 1(b).
    \4\ See CHX Rules, Article 20, Interpretation and Policy .01.
---------------------------------------------------------------------------

    While these rules provided a reasonable way to handle the opening
as the Exchange transitioned from its specialist trading model to its
new fully-automated trading model, the Exchange believes that it is no
longer appropriate to base its opening time on the actions taken by
other markets. Through this filing, the Exchange would amend its rules
to permit trading to begin at 8:30 a.m., except for trading in
specified exchange-traded funds, which would begin at 7:20 a.m.\5\
---------------------------------------------------------------------------

    \5\ See Proposed CHX Rules, Article 20, Rule 1(b). The Exchange
represents that Exchange-traded funds that begin trading at 7:20
a.m. would be announced, from time to time, by the Exchange in a
customer service notification or other type of update. The only
exchange-traded fund currently trading at 7:20 a.m. is the
streetTRACKS[reg] Gold Trust. Telephone conversation between Ellen
Neely, President and General Counsel, CHX, Richard Holley III,
Senior Special Counsel, Division of Market Regulation
(``Division''), Commission, and Sonia Trocchio, Special Counsel,
Division, Commission (October 18, 2007).
---------------------------------------------------------------------------

    In conjunction with this change to the opening time of the
Exchange's market, the Exchange would make two other changes to its
rules. First, the Exchange would eliminate the opening cross order
type. These cross orders, which are designed to execute at the primary
market opening price, likely could no longer be effectively executed on
the Exchange, once the proposed change is made to the time of the
Exchange's opening.\6\ In addition, the Exchange would add a new rule
that prevents immediate or cancel (``IOC'') market orders from being
accepted until either (i) the primary market in a security has opened
trading in that security or (ii) two senior officers of the Exchange
have determined that it is appropriate for the Exchange to accept IOC
market orders.\7\ This change is designed to prevent market orders from
being executed at prices that are far away from the primary market
opening price, when that market ultimately opens.
---------------------------------------------------------------------------

    \6\ If the Exchange's systems allow its participants to begin
trading before the primary market opens trading in a particular
security, an opening cross order (which must execute at the primary
market opening price) might violate the protected quotations of
other markets. To avoid this potential result, the Exchange believes
that it is appropriate to eliminate this order type.
    \7\ See Proposed CHX Rules, Article 1, Rule 2(n) and Article 20,
Rule 4(b)(13). For purposes of this rule, another exchange would be
considered to have opened for trading in a security when the first
trade in that security occurs in that market on or after 8:30 a.m.
The Exchange has stated that two senior officers of the Exchange
might decide that it is appropriate to allow IOC market orders to be
accepted if, for example, the primary market has announced that it
will open later than expected, but other markets are open to provide
additional liquidity. Telephone conversation between Ellen Neely,
President and General Counsel, CHX, Richard Holley III, Senior
Special Counsel, Division, Commission, and Sonia Trocchio, Special
Counsel, Division, Commission (October 18, 2007).
---------------------------------------------------------------------------

2. Statutory Basis
    The CHX believes the proposal is consistent with the requirements
of the Act and the rules and regulations thereunder that are applicable
to a national securities exchange, and, in particular, with the
requirements of Section 6(b).\8\ The proposed rule change is consistent
with Section 6(b)(5) of the Act \9\ because it would promote just and
equitable principles of trade, remove impediments to, and perfect the
mechanism of, a free and open market and a national market system, and,
in general, protect investors and the public interest by permitting the
Exchange to begin trading at 8:30 a.m., without regard to whether the
primary market in a particular security is open.
---------------------------------------------------------------------------

    \8\ 15 U.S.C. 78(f)(b).
    \9\ 15 U.S.C. 78(f)(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    CHX does not believe that the proposed rule change will impose any
burden on competition that is not necessary or appropriate in
furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    The Exchange neither solicited nor received comments on the
proposal.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Within 35 days of the date of publication of this notice in the
Federal Register or within such other period (i) as the Commission may
designate up to 90 days of such date if it finds such longer period to
be appropriate and publishes its reasons for so finding or
    (ii) As to which the CHX consents, the Commission will:
    (A) By order approve the proposed rule changes, or
    (B) Institute proceedings to determine whether the proposed rule
changes should be disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml.
); or     Send an e-mail to<EMAIL_ADDRESS>Please include

File Number SR-CHX-2007-23 on the subject line.

Paper Comments

     Send paper comments in triplicate to Nancy M. Morris,
Secretary,

Securities and Exchange Commission, 100 F Street, NE., Washington, DC
20549-1090.

    All submissions should refer to File Number SR-CHX-2007-23. This
file number should be included on the subject line if e-mail is used.
To help the Commission process and review your comments more
efficiently, please use only one method. The Commission will post all
comments on the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml
). Copies of the submission, all subsequent amendments,

all written statements with respect to the proposed rule change that
are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person,
other than those that may be withheld from the public in accordance
with the provisions of 5 U.S.C. 552, will be available for inspection
and copying in the Commission's Public Reference Room, 100 F Street,
NE., Washington, DC 20549, on official business days between the hours
of 10 a.m. and 3 p.m. Copies of such filing also will be available for
inspection and copying at the principal office of the CHX. All comments
received will be posted without change; the Commission does not edit
personal identifying information from submissions. You should submit
only information that you wish to make available publicly. All
submissions should refer to File Number SR-CHX-2007-23 and should be
submitted on or before November 23, 2007.

    For the Commission, by the Division of Market Regulation,
pursuant to delegated authority.\10\
---------------------------------------------------------------------------

    \10\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Nancy M. Morris,
Secretary.
 [FR Doc. E7-21455 Filed 10-31-07; 8:45 am]

BILLING CODE 8011-01-P


[Federal Register Volume 82, Number 21 (Thursday, February 2, 2017)]
[Notices]
[Pages 9071-9072]
[FR Doc No: 2017-02166]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Docket ID: FEMA-2017-0006; OMB No. 1660-0126]

Agency Information Collection Activities: Proposed Collection;
Comment Request; FEMA Preparedness Grants: Emergency Management
Performance Grant (EMPG)

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Federal Emergency Management Agency, as part of its
continuing effort to reduce paperwork and respondent burden, invites
the general public and other Federal agencies to take this opportunity
to comment on an extension, without change, of a currently approved
information collection. In accordance with the Paperwork Reduction Act
of 1995, this notice seeks comments concerning information collection
activities required to administer the FEMA Emergency Management
Performance Grants (EMPG).

DATES: Comments must be submitted on or before April 3, 2017.

ADDRESSES: To avoid duplicate submissions to the docket, please use
only one of the following means to submit comments:
    (1) Online. Submit comments at www.regulations.gov under Docket ID
FEMA-2017-0006. Follow the instructions for submitting comments.
    (2) Mail. Submit written comments to Docket Manager, Office of
Chief Counsel, DHS/FEMA, 500 C Street SW., 8NE, Washington, DC 20472-
3100.
    All submissions received must include the agency name and Docket
ID. Regardless of the method used for submitting comments or material,
all submissions will be posted, without change, to the Federal
eRulemaking Portal at http://www.regulations.gov, and will include any
personal information you provide. Therefore, submitting this
information makes it public. You may wish to read the Privacy Act
notice that is available via the link in the footer of
www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Angel McLaurine-Qualls, Program
Specialist, DHS FEMA, Grant Programs Directorate,<PHONE_NUMBER>. You may
contact the Records Management Division for copies of the proposed

collection of information at email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: The Emergency Management Performance Grants
Program (EMPG) helps facilitate a national and regional all-hazards
approach to emergency response, including the development of a
comprehensive program of planning, training, and exercises that
provides a foundation for effective and consistent response to any
threatened or actual disaster or emergency, regardless of the cause.
Section 662 of the Post-Katrina Emergency Management Reform Act of 2006
(6 U.S.C. 762), as amended, empowers the FEMA Administrator to continue
implementation of an Emergency Management Performance Grants Program to
make grants to States to assist State, local, and tribal governments in
preparing for all hazards, as authorized by the Robert T. Stafford
Disaster Relief and Emergency Assistance Act (42 U.S.C. 5121 et seq.).

Collection of Information

    Title: FEMA Preparedness Grants: Emergency Management Performance
Grant (EMPG).
    Type of Information Collection: Extension, without change, of a
currently approved information collection.
    OMB Number: 1660-0126.
    FEMA Forms: None.
    Abstract: The Emergency Management Performance Grants (EMPG)
Program assists State and local governments in enhancing and sustaining
all-hazards emergency management capabilities. The EMPG Work Plan
narrative must demonstrate how proposed projects address gaps,
deficiencies, and capabilities in current programs and the ability to
provide enhancements consistent with the purpose of the program and
guidance provided by FEMA. FEMA uses the information to provide
details, timelines, and milestones on proposed projects.
    Affected Public: State, Local, Territorial, or Tribal Government.
    Number of Respondents: 58.
    Number of Responses: 58.
    Estimated Total Annual Burden Hours: 174 hours.
    Estimated Cost: The estimated annual cost to respondents for the
hour burden is $9,008.26. There are no annual costs to respondents
operations and maintenance costs for technical services. There is no
annual start-up or capital costs. The cost to the Federal Government is
$415,206.

Comments

    Comments may be submitted as indicated in the ADDRESSES caption
above. Comments are solicited to (a) evaluate whether the proposed data
collection is necessary for the proper performance of the agency,
including whether the information shall have practical utility; (b)
evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (c) enhance the quality, utility, and
clarity of the information to be collected; and (d) minimize the burden
of the collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses.

    Dated: January 23, 2017.
Richard W. Mattison,
Records Management Program Chief, Mission Support, Federal Emergency
Management Agency, Department of Homeland Security.
[FR Doc. 2017-02166 Filed 2-1-17; 8:45 am]
 BILLING CODE 9111-46-P


[Federal Register: March 23, 2006 (Volume 71, Number 56)]
[Notices]
[Page 14769-14772]
[DOCID:fr23mr06-86]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-53496; File No. SR-Phlx-2005-62]

Self-Regulatory Organizations; Philadelphia Stock Exchange, Inc.;
Notice of Filing of Proposed Rule Change and Amendment No. 1 Thereto
Relating to Amending Exchange Delisting Rules To Conform to Recent
Amendments to Commission Rules Regarding Removal From Listing and
Withdrawal From Registration

March 16, 2006.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act'')&thnsp\1\, and Rule 19b-4 \2\ thereunder, notice is hereby
given that on October 25, 2006, the Philadelphia Stock Exchange, Inc.
(``Phlx'' or ``Exchange'') filed with the Securities and Exchange
Commission (``SEC'' or ``Commission'') the proposed rule change as
described in Items I, II, and III below, which Items have been prepared
by the Phlx. On January 4, 2006, Phlx filed Amendment No. 1 to the
proposed rule change.\3\ The Commission is publishing this notice to
solicit comments on the proposed rule change, as amended, from
interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ In Amendment No. 1, Phlx amended its rule text and the
purpose section of the Exchange's Form 19b-4 to clarify the
effective date of the proposed rule change and revised Phlx Rule 809
to state that an issuer proposing to withdraw a security from
listing on the Exchange must provide a copy of Form 25 to the
Exchange upon filing with the Commission.

---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Phlx proposes to amend Phlx Rules 809 (Issuer Request for
Removal and Delisting of Securities), 810 (Suspension and Delisting
Policies Based on Exchange Findings), and 811 (Delisting Policies and
Procedures) in view of the recent adoption by the Commission of
amendments to its rules \4\ that would streamline the procedure for
removing from listing, and withdrawing from registration, securities
under Section 12(b) of the Act.\5\ The text of the proposed rule change
is below. Proposed new language is italicized; proposed deletions are
in [brackets].
---------------------------------------------------------------------------

    \4\ See Securities Exchange Act Release No. 52029 (July 14,
2005), 70 FR 42456 (July 22, 2005) (the ``Delisting Release'').
Changes to Commission rules under the Act pursuant to the Delisting
Release will not be operative until April 24, 2006.
    \5\ 15 U.S.C. 78s(b)(1).
---------------------------------------------------------------------------

* * * * *

Rule 809

Issuer Request for Removal and Delisting of Securities

* * * * *
    The following will be the operative text of Rule 809 effective as
of April 24, 2006:
    An issuer proposing to withdraw a security from listing on the
Exchange shall submit the following:
    A certified copy of a resolution adopted by the Board of Directors
of the issuer authorizing withdrawal from listing and registration and
a statement setting forth in detail the reasons for the proposed
withdrawal and the facts in support thereof.
    The issuer may be required to submit the proposed withdrawal to the
security holders for their vote at a meeting for which proxies are
solicited provided the stock is not also listed on another Exchange
having similar requirements.
    An issuer proposing to withdraw a security from listing on the
Exchange shall do so by electronically submitting to the Securities and
Exchange Commission Form 25 via the EDGAR system in compliance with all
of the requirements of Rule 12d2-2(c) under the Exchange Act, and shall
simultaneously provide a copy of such Form 25 to the Exchange.
* * * * *

Rule 810

Suspension and Delisting Policies Based on Exchange Findings

* * * * *
    The following will be the operative text of Rule 810 effective as
of April 24, 2006:
    (a) through (c)--No Change.
    Commentary:
    .01 An application by the Exchange to strike a security from
listing and/or registration will be submitted to the Securities and
Exchange Commission electronically on Form 25 via the EDGAR system, and
a copy of the application on Form 25 will be promptly delivered to the
issuer.
* * * * *

Rule 811

Delisting Policies and Procedures

* * * * *
    The following will be the operative text of Rule 811 effective as
of April 24, 2006:
    (a) through (f)--No Change.
    (g) At the conclusion of the hearing the Committee will present its
findings to the Board of Governors so that a final determination can be
made. Such decision shall be final. If the Committee or the Board
determines that the security of the issuer should be removed from
listing, an application shall be submitted by the Exchange to the
Securities and Exchange Commission (``Commission'') to strike the
security from listing and registration and a copy of such application
shall be furnished to the issuer in accordance with Section 12 of the
Exchange Act and the rules promulgated thereunder. If the decision is
that the security should not be removed from listing, the issuer will
receive a notice to that effect from the Exchange.
    An application by the Exchange to strike a security from listing
and/or registration will be submitted to the Commission electronically
on Form 25 via the EDGAR system, and a copy of the application on Form
25 will be promptly delivered to the issuer.
    The actions required to be taken by the Exchange and issuers to
strike a security from listing and/or registration [for routine reason,
such as redemption, maturity and retirement, is] are set forth in Rule
12d2-2[(a)] and Rule 19d-1 promulgated under the Exchange Act.
    The relevant portions of [the] Section 12 of the Exchange Act and
Rules promulgated thereunder pertaining to the suspension, removal or
withdrawal of registration/and or listing of securities [for all other
reasons], and the timing thereof are summarized below:
    (1) [SEC authorization for w]Withdrawal of registration and/or
striking for certain corporate events from listing of Exchange listed
security--Section 12(d) of the Exchange Act and Rule 12d2-d(a)
thereunder;
    (2) suspension of trading by Exchange--Rule 12d2-1 under the
Exchange Act;
    (3) application of Exchange to strike security from listing and or/
registration and notice provisions--Rule 12d2-2 (a) and (b) [(c) and
(e)] under the Exchange Act;[ or]
    (4) application of issuer to withdraw from listing and registration
and notice provisions--Rule 12d2-2([d) and (e]c) under the Exchange
Act[.];
    (5) timing and effectiveness of application by issuer or Exchange
to strike a security from listing and/or registration--Rule 12d2-2(d)
under the Exchange Act; or
    (6) exemption of certain standardized options and futures products
from Section 12(d) of the Act--Rule 12d2-2(e).
    In appropriate circumstances, when the Exchange is considering
delisting because a company no longer meets the requirements for
continued listing, a company may[, with the consent of the Exchange,]
file a delisting application electronically on Form 25 via the EDGAR
system, and shall no fewer than ten days prior to filing Form 25
provide written notice to the Exchange, provided that it states in its
application that it [is no longer eligible for continued listing on the
Exchange] has complied with the rules of the Exchange and the
requirements of Rule 12d2-2(c) under the Exchange Act governing the
voluntary withdrawal of the class of securities from listing and
registration on the Exchange.\6\
---------------------------------------------------------------------------

    \6\ Phlx intends to amend its rule text to clarify that an
issuer that is below the continued listing policies and standards of
the Exchange and seeks to voluntarily apply to withdraw a class of
securities from listing must disclose that it is no longer eligible
for continued listing in its statement of material facts relating to
the reason for withdrawal from listing, its public press release,
and its Web site notice. Telephone conversation between Jurij
Trypupenko, Director, Phlx, and Ronesha A. Butler, Special Counsel,
Division of Market Regulation, Commission, on March 15, 2006.
---------------------------------------------------------------------------

    Pursuant to this rule, the Exchange will provide public notice of
its final determination to remove a security from listing and/or
registration by issuing a press release and posting a notice on its web
site. Such notice will be disseminated no fewer than ten days before
the delisting becomes effective pursuant to paragraph (d)(1) of Rule
12d2-2 under the Exchange Act, and will remain posted on the web site
until the delisting is effective.
* * * * *

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Phlx included statements
concerning the purpose of, and basis for, the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. The Phlx has prepared summaries, set forth in sections
A, B, and C below, of the most significant aspects of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The purpose of the proposed rule change is to conform the
Exchange's Rules 809, 810, and 811 to the Commission's recent actions
regarding streamlining the procedures for removing from listing, and
withdrawing from registration, securities under Section 12(d) of the
Act.
    On July 14, 2005, the Commission published the Delisting Release
making changes to the Commission's rules governing removal from listing
and registration and instituting electronic submission of Form 25.\7\
In the Delisting Release, the Commission, among other things, adopted
amendments to Rules 12d2-2 and 19d-1 under the Act and Form 25
thereunder,\8\ to indicate that national securities exchanges and
issuers that seek to delist and/or deregister securities under Section
12(d) of the Act will do so by electronically filing Form 25 via the
Commission's Electronic Data Gathering, Analysis, and Retrieval
(``EDGAR'') system.\9\
---------------------------------------------------------------------------

    \7\ See Securities Exchange Act Release No. 52029 (July 14,
2005), 70 FR 42456 (July 22, 2005).
    \8\ 17 CFR 240.12d2-2, 17 CFR 240.19d-1, and 17 CFR Part 249.25.
The Exchange likewise adopted amendments to Rule 101 of Regulation
S-T, 17 CFR 232.101.
    \9\ To permit the EDGAR system to differentiate between a Form
25 filed by exchanges and by issuers, the Commission established
that a Form 25 filed by exchanges would have the EDGAR submission
type of 25-NSE and a Form 25 filed by issuers would have the EDGAR
submission type of 25.
---------------------------------------------------------------------------

    Phlx Rule 811 (Delisting Policies and Procedures) currently
establishes a procedure for the Exchange to delist a company that is
below the Exchange's continued listing criteria (and not able to
otherwise qualify under an initial listing standard), which includes an
opportunity for a company to come into compliance, provision of notice
of the Exchange staff's decision to delist, and opportunity for a
company to appeal the decision to a committee designated by the
Exchange's board of directors; and indicates that the Exchange will
follow Section 12(d) of the Act and Commission Rule 12d2-2.
    The Exchange proposes changes to Phlx Rule 811 to conform it to the
Delisting Release. The proposed changes to Phlx Rule 811 include
language modifications that: indicate that applications by the Exchange
to strike a security from listing and/or registration will be submitted
on Form 25 via EDGAR, and a copy will be promptly delivered to the
issuer; add a reference to Commission Rule 19d-1 under the Act in terms
of the Exchange and issuers following the procedures established in
Commission Rule 19d-1 along with Commission Rule 12d2-2 under the Act;
expand and modify references to Commission Rule 12d2-2 so that they are
commensurate with the Delisting Release; and provide for public notice
of the Exchange's final determination to remove a security from listing
and/or registration by issuing a press release and posting a notice on
its web site for the requisite period of time. The proposed changes to
Phlx Rule 811 also relate to the exemption of certain standardized
options and futures products from Section 12(d) of the Act.
    Phlx Rule 810 (Suspension and Delisting Policies Based on Exchange
Findings) currently provides that if an issuer cannot demonstrate
proper listing compliance it will be subject to delisting procedures
pursuant to Phlx Rule 811; and that if the entire outstanding amount of
a class, issue or series is retired through payment at maturity or
through redemption, reclassification or otherwise, the Exchange may
give notice to the SEC on Form 25. The Exchange proposes a change to
clarify that Form 25 will be electronically filed via EDGAR, in
compliance with the Delisting Release.
    Phlx Rule 809 (Issuer Request for Removal and Delisting of
Securities) currently provides that if an issuer desires to withdraw a
security from listing it must, among other things, provide a certified
copy of a resolution adopted by the Board of Directors of the issuer
authorizing withdrawal from listing and registration and a statement
setting forth in detail the reasons for the proposed withdrawal and the
facts in support thereof. The Exchange proposes to clarify that for
such requests an issuer shall use Form 25 electronically filed via
Edgar in compliance with all of the requirements of Commission Rule
12d2-2(c) under the Act for such requests, in compliance with the
Delisting Release.
    The Exchange believes that the proposed changes conform its rules
to the Delisting Release and streamline the process for delisting and/
or deregistration.
2. Statutory Basis
    The Exchange believes that its proposal, as amended, is consistent
with Section 6(b) of the Act \10\ in general, and furthers the
objectives of Section 6(b)(5) of the Act \11\ in particular, in that it
is designed to promote just and equitable principles of trade, to
remove impediments to and to perfect the mechanism of a free and open
market and a national market system and, in general, to protect
investors and the public interest.
---------------------------------------------------------------------------

    \10\ 15 U.S.C. 78f(b).
    \11\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Phlx does not believe that the proposed rule change, as
amended, will impose any burden on competition not necessary or
appropriate in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    No written comments were either solicited or received.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Within 35 days of the date of publication of this notice in the
Federal Register or within such longer period (i) as the Commission may
designate up to 90 days of such date if it finds such longer period to
be appropriate and publishes its reasons for so finding or (ii) as to
which Phlx consents, the Commission will:
    (A) By order approve such rule change, or
    (B) Institute proceedings to determine whether the proposed rule
change should be disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change, as amended, is consistent with the Act. Comments may be
submitted by any of the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml
); or

     Send an e-mail to<EMAIL_ADDRESS>Please include
File Number SR-Phlx-2005-62 on the subject line.

Paper Comments

     Send paper comments in triplicate to Nancy M. Morris,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.
    All submissions should refer to File Number SR-Phlx-2005-62. This
file number should be included on the subject line if e-mail is used.
To help the Commission process and review your comments more
efficiently, please use only one method. The Commission will post all
comments on the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml
). Copies of the submission, all subsequent amendments,

all written statements with respect to the proposed rule change that
are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person,
other than those that may be withheld from the public in accordance
with the provisions of 5 U.S.C. 552, will be available for inspection
and copying in the Commission's Public Reference Room. Copies of the
filing also will be available for inspection and copying at the
principal office of the Phlx.
    All comments received will be posted without change; the Commission
does not edit personal identifying information from submissions. You
should submit only information that you wish to make available
publicly. All submissions should refer to File Number SR-Phlx-2005-62
and should be submitted on or before April 13, 2006.

    For the Commission, by the Division of Market Regulation,
pursuant to delegated authority.\12\
---------------------------------------------------------------------------

    \12\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Nancy M. Morris,
Secretary.
[FR Doc. E6-4183 Filed 3-22-06; 8:45 am]

BILLING CODE 8010-01-P